Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advances in colon capsule endoscopy: a review of current applications and challenges.

Frontiers in gastroenterology (Lausanne, Switzerland)·2026
Same author

Real-world evidence for passive video-based cardiac monitoring from smartphones used by patients with a history of AF.

Journal of electrocardiology·2025
Same author

War and disaster are forcing a major rethink around mass casualty management.

BMJ military health·2023
Same author

Timely Presence of Mother with their Newborns on Admission to PICU.

Irish medical journal·2023
Same author

Measurements of pulse rate using facial video cameras from smart devices in patients diagnosed with atrial fibrillation.

Journal of electrocardiology·2023
Same author

Pre-hospital prediction of adverse outcomes in patients with suspected COVID-19: Development, application and comparison of machine learning and deep learning methods.

Computers in biology and medicine·2022
Same journal

Prevalence, duration, and clinical implications of continuous glucose monitor measurement limit capping in type 1 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same journal

Disentangling the effect of brain insulin resistance on brain health (BIR-BrainHealth): Rationale and study protocol.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same journal

Clinical characteristics and in-hospital mortality among insulin pump users with acute coronary syndrome in the predominantly open-loop era: A UK-wide MINAP registry analysis.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same journal

Hyperlipidaemia in youth with type 1 diabetes: Are current guidelines clinically useful?

Diabetic medicine : a journal of the British Diabetic Association·2026
Same journal

Hypoglycaemia care: Time to modernise our treatment standards.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same journal

Continuing automated insulin delivery systems during hospitalisation with type 1 diabetes: A thematic literature review.

Diabetic medicine : a journal of the British Diabetic Association·2026
See all related articles

Related Experiment Video

Updated: May 20, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Setting research priorities for Type 1 diabetes.

R Gadsby1, R Snow, A C Daly

  • 1Warwick Medical School, University of Warwick, Oxford, UK. r.gadsby@warwick.ac.uk

Diabetic Medicine : a Journal of the British Diabetic Association
|July 25, 2012
PubMed
Summary
This summary is machine-generated.

This study successfully identified the top 10 research priorities for Type 1 diabetes by engaging patients, carers, and health professionals. The findings ensure future research addresses the most important questions in diabetes care.

More Related Videos

Generating Human Pancreatic Tissue Slices to Study Endocrine and Exocrine Pancreas Physiology
08:16

Generating Human Pancreatic Tissue Slices to Study Endocrine and Exocrine Pancreas Physiology

Published on: March 15, 2024

Related Experiment Videos

Last Updated: May 20, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Generating Human Pancreatic Tissue Slices to Study Endocrine and Exocrine Pancreas Physiology
08:16

Generating Human Pancreatic Tissue Slices to Study Endocrine and Exocrine Pancreas Physiology

Published on: March 15, 2024

Area of Science:

  • Endocrinology
  • Clinical Research
  • Patient-Centered Outcomes

Background:

  • Traditional research priority setting often excludes patient and clinician perspectives.
  • This can lead to research questions that do not address the most pressing needs in Type 1 diabetes management.
  • Patient and public involvement is crucial for relevant and impactful research.

Purpose of the Study:

  • To gather and prioritize uncertainties regarding Type 1 diabetes treatment from patients, carers, and health professionals.
  • To develop a consensus-driven top 10 list of research priorities using a structured methodology.
  • To ensure research aligns with the lived experiences and clinical realities of Type 1 diabetes.

Main Methods:

  • Established a priority-setting partnership involving patients, carers, health professionals, and diabetes organizations.
  • Collected uncertainties via online and paper surveys, followed by collation and interim prioritization.
  • Conducted a final priority-setting workshop to agree on the top 10 research priorities.

Main Results:

  • An initial 1141 uncertainties were collected and refined into 88 indicative questions.
  • Voting and a final workshop narrowed these down to a definitive top 10 research priorities for Type 1 diabetes.
  • The process successfully engaged diverse stakeholders in research agenda setting.

Conclusions:

  • The James Lind Alliance methodology is effective for developing agreed-upon research priorities in Type 1 diabetes.
  • This collaborative approach ensures that patient, carer, and health professional perspectives are central to research direction.
  • The resulting top 10 list provides a clear roadmap for future Type 1 diabetes research.